ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 1107

$901K Total Retail Price of All Prescriptions

Rank: 123 out of 1107

676 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 676 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 676 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 12,965 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 662 547 S3 1 1
FUROSEMIDE 511 388 2 7
LISINOPRIL 454 301 3 2
SIMVASTATIN 446 349 4 5
LEVOTHYROXINE SODIUM 434 331 5 3
POTASSIUM CHLORIDE 396 308 6 14
RANITIDINE HCL 380 329 7 21
METOPROLOL TARTRATE 380 304 7 10
CITALOPRAM HBR 360 318 9 17
OMEPRAZOLE 356 276 10 4
METFORMIN HCL 336 217 11 8
AMLODIPINE BESYLATE 305 258 12 6
JANTOVEN 238 199 13 214
GABAPENTIN 237 158 14 9
ATORVASTATIN CALCIUM 236 193 15 13
TAMSULOSIN HCL 224 190 16 30
CLOPIDOGREL 219 188 17 28
DONEPEZIL HCL 203 203 18 32
ATENOLOL 203 156 18 19
MELOXICAM 191 130 20 25
NEXIUM 188 153 21 18
TRAZODONE HCL 178 145 22 33
PLAVIX 176 154 23 39
RISPERIDONE 171 147 24 79
CARVEDILOL 165 135 25 27
LACTULOSE 157 141 26 89
AZITHROMYCIN 156 106 27 35
TRAMADOL HCL 145 119 28 26
METOCLOPRAMIDE HCL 144 139 29 116
LANTUS 142 94 30 49
POLYETHYLENE GLYCOL 3350 137 115 31 46
PREDNISONE 135 115 32 40
NAMENDA 130 110 33 42
SODIUM CHLORIDE 123 112 34 186
CLONIDINE HCL 122 95 35 53
NABUMETONE 119 24 36 181
ISOSORBIDE MONONITRATE ER 118 107 37 34
HYDROCHLOROTHIAZIDE 116 66 38 11
LEVOFLOXACIN 114 81 39 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 76 40 88
HYDROXYZINE PAMOATE 108 68 R 40 152
SPIRONOLACTONE 102 84 42 72
CYCLOBENZAPRINE HCL 101 44 R 43 56
WARFARIN SODIUM 100 58 44 15
HYDRALAZINE HCL 96 83 45 99
PROMETHAZINE HCL 95 73 R 46 44
MEGESTROL ACETATE 93 84 R 47 178
JANUVIA 92 75 48 60
IPRATROPIUM-ALBUTEROL 91 84 49 154
LIPITOR 87 85 50 109
EXELON 83 83 51 103
METOPROLOL SUCCINATE 81 54 52 16
ZOLPIDEM TARTRATE 81 52 52 22
IBUPROFEN 80 27 54 63
NYSTATIN 79 54 55 110
ALENDRONATE SODIUM 75 68 56 41
PHENYTOIN SODIUM EXTENDED 72 51 57 147
MUPIROCIN 70 52 58 161
ALLOPURINOL 69 55 59 36
PRAVASTATIN SODIUM 69 54 59 12
ENDOCET 64 50 S2 61 91
DIGOXIN 64 64 61 52
CARBIDOPA-LEVODOPA 62 62 63 122
SERTRALINE HCL 62 31 63 20
PANTOPRAZOLE SODIUM 62 51 63 30
CEPHALEXIN 62 50 63 81
COMBIVENT 60 39 67 112
LIDODERM 59 35 68 140
QUETIAPINE FUMARATE 59 49 68 94
ENALAPRIL MALEATE 59 55 68 98
FENTANYL 57 46 S2 71 105
DILTIAZEM 24HR CD 56 50 72 126
CRESTOR 55 38 73 23
HALOPERIDOL 55 42 73 225
ABILIFY 55 46 73 170
LEVETIRACETAM 55 21 73 141
SPIRIVA 52 52 77 57
NOVOLOG 52 32 77 127
NOVOLIN R 51 49 79 187
AVODART 50 45 80 204
BUSPIRONE HCL 50 43 80 107
CIPROFLOXACIN HCL 50 36 80 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.